Add to ORKGUnilateral lesions of nigrostriatal dopamine ( DA) pathways with 6-hydroxydopamine (6-OHDA) can be used to obtain a model of Parkinson's disease in the mouse. In the present study we examine two types of unilateral 6-OHDA lesions in the mouse for their ability to induce stable motor deficits and supersensitive molecular and behavioural response to L-DOPA
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Mice with striatal 6-hydroxydopamine (6-OHDA) lesions are widely used as a model to study the effect...
L-DOPA-induced dyskinesia is a major complication of L-DOPA pharmacotherapy in Parkinson's disease, ...
6-Hydroxydopamine (6-OHDA) lesions are being used in the mouse for basic research on Parkinson's dis...
In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly ...
In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly ...
In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly ...
Parkinson’s disease (PD) is a prevalent movement disorder characterized by the progressive loss of d...
The most frequently used animal models for Parkinson's disease (PD) utilize unilateral injection of ...
The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing...
The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing...
Parkinson's disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydop...
The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing...
Parkinson's disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydop...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Mice with striatal 6-hydroxydopamine (6-OHDA) lesions are widely used as a model to study the effect...
L-DOPA-induced dyskinesia is a major complication of L-DOPA pharmacotherapy in Parkinson's disease, ...
6-Hydroxydopamine (6-OHDA) lesions are being used in the mouse for basic research on Parkinson's dis...
In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly ...
In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly ...
In the 6-hydroxydopamine (6-OHDA) lesioned rodent the location of the lesion produces significantly ...
Parkinson’s disease (PD) is a prevalent movement disorder characterized by the progressive loss of d...
The most frequently used animal models for Parkinson's disease (PD) utilize unilateral injection of ...
The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing...
The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing...
Parkinson's disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydop...
The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing...
Parkinson's disease is most commonly modelled via unilateral infusion of the neurotoxin 6-hydroxydop...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Mice with striatal 6-hydroxydopamine (6-OHDA) lesions are widely used as a model to study the effect...